Function Health Stock
| Valuation | $2.5B1 |
| Valuation Date | Nov 19, 2025 |
| Implied Valuation | $3.75B |
| Last Price | $60.00 |
| 52-Week High | $65.00 |
| 52-Week Low | $40.00 |
| YTD Return | -7.69% |
| 1-Year Return | +50.00% |
| 3-Year Return | n/a |
| Total Funding | $804M2, 3, 4 |
| Latest Round Amount | $450M2 |
| Latest Round | Growth Financing |
| Funding Rounds | 4 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Function Health
Function Health is a preventive-health platform that gives members access to extensive lab testing and personalized insights into their health. For an annual membership, members get more than 160 biomarker blood tests spanning heart, hormones, thyroid, metabolic health, cancer signals and toxins, with results tracked over time and explained by clinicians. The company also offers 22-minute full-body MRI scans through its 2025 acquisition of imaging startup Ezra. It has since built a Medical Intelligence Lab that applies AI to members' combined lab, imaging and wearable data. Function makes money primarily by selling annual memberships priced at several hundred dollars, plus add-on diagnostic services such as full-body scans.
Invest in Function Health
Function Health is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
Related Companies
News
Function Partners with NYU Grossman School of Medicine for Longitudinal AI Disease Detection
The research collaboration pairs NYU Grossman's clinical datasets with Function's lab and imaging pipeline to build next-generation preventive AI models through its Medical Intelligence Lab.
Function Announces Partnership with NYU Grossman School of Medicine to Launch Landmark Research Aimed at Advancing Earlier Disease Detection
Function partnered with NYU Grossman School of Medicine on August 12, 2026 to develop AI models for early detection of cancer, cognitive decline, and cardiometabolic disease using longitudinal lab, im...
Function Health lands $450M in growth financing to scale tech-enabled preventive health
Fierce Healthcare reported Function Health's $450 million General Catalyst CVF growth financing to expand its membership-based lab testing and imaging platform serving 500,000-plus members.
Function Secures $450 Million Growth Financing from General Catalyst's Customer Value Fund
Function closed $450 million in non-dilutive growth financing from General Catalyst's Customer Value Fund to accelerate customer acquisition and platform expansion.
Robinhood launches new Platinum Card with Function as a Core Benefit
Robinhood named Function Health a flagship benefit of its new Platinum Card, giving eligible cardholders a complimentary annual Function membership worth $365 that includes more than 160 lab tests and...
Function Acquires Getlabs, Bringing Healthcare Directly to You
Function acquired Getlabs to offer members at-home or in-office blood draws alongside its existing Quest Diagnostics lab network.
Function Expands AI Connectors with Perplexity Health
Function will let members securely connect lab results and clinician-reviewed summaries to Perplexity Health, extending its portfolio of AI health-data integrations.
Sweetgreen Launches New Menu in Collaboration with Function Health, Designed by Dr. Mark Hyman
LOS ANGELES--(BUSINESS WIRE)--Today, Sweetgreen and Function, in collaboration with Function's co-founder and Chief Medical Officer Mark Hyman, MD, announced a menu that aims to be first-of-its-kind, ...
Function Health raises $298M Series B at $2.5B valuation
Function Health closed a $298 million Series B led by Redpoint Ventures at a $2.5 billion valuation, and unveiled its Medical Intelligence Lab, a doctor-trained generative AI effort that answers membe...
Function Health Honored by Goldman Sachs for Entrepreneurship
Jonathan Swerdlin, Co-Founder & CEO, Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit NEW YORK , Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recogni...
Function Health: 2025 TIME100 Most Influential Companies
TIME named Function Health to its 2025 list of the 100 most influential companies, highlighting its push toward proactive, preventive care through twice-yearly panels of more than 100 lab tests.
Function Health buys full-body scanning company Ezra
Function Health acquired full-body MRI scanning startup Ezra and launched a 22-minute scan for $499, adding AI-powered imaging to its blood-testing membership.
Function pockets $53M for personalized health testing backed by celebrity investors
Function Health closed a Series A led by Andreessen Horowitz's Bio + Health fund that brought its total funding to $53 million, with celebrity backers including Matt Damon, Pedro Pascal and Kevin Hart...